May 15, 2018 CTT Pharmaceutical Holdings, Inc. Provides Corporate Update with Emphasis on Patent Portfolio By Flodesign | Press Release
April 16, 2018 Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical By Flodesign | Press Release
February 28, 2018 Aurora Cannabis Announces Final Regulatory Approval for CanniMed Therapeutics Acquisition By Flodesign | Industry News
February 21, 2018 UPDATE–CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized Cannabinoids, Opioids and Other Pharmaceutical Agents By Flodesign | Press Release
February 20, 2018 Israel Scientific Study: Cannabis Safe and Effective for Regular Use in the Elderly; Can Decrease the Use of Other Prescription Medicines, Including Opioids By Flodesign | Industry News
February 6, 2018 AURORA CANNABIS AND CANNIMED THERAPEUTICS FILE OFFER DOCUMENTS FOR PREVIOUSLY ANNOUNCED FRIENDLY ACQUISITION By Flodesign | Industry News
January 24, 2018 Aurora Cannabis and CanniMed Therapeutics Agree to Terms on Friendly Transaction By Flodesign | Press Release
January 10, 2018 CTT Pharmaceutical Holdings, Inc., (CTTH) Announces U.S. Patent for Therapeutic Composition for Treating Psoriasis with Cannabidiol and Corticosteroids By Flodesign | Press Release
November 14, 2017 CTT Pharmaceuticals Holdings, Inc. Provides Corporate Update By Flodesign | Press Release
April 13, 2017 Marjiuana bill to unleash a sea change in public policy not seen since the 1930s By Flodesign | Industry News
April 6, 2017 Aphria takes medical marijuana model to U.S. with $25 million investment in Florida By Flodesign | Industry News
April 3, 2017 Meet the NFF: New Group to Lobby Trump, Congress on Cannabis By Flodesign | Industry News
March 30, 2017 Marijuana ETF ‘the most scrutinized fund that we’ve ever launched,’ Horizons CEO says By Flodesign | Industry News
March 27, 2017 Liberals to announce marijuana will be legal by July 1, 2018 By Flodesign | Industry News
February 22, 2017 Independent Laboratory Analysis Confirms CanniMed Medical Cannabis Products Free from Pesticides, Fungicides, and Plant Growth Regulators By Flodesign | Industry News
February 17, 2017 CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film (ODF) Wafer By Flodesign | Press Release
February 17, 2017 CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film (ODF) Wafer By Flodesign | Industry News, Press Release
January 31, 2017 CanniMed Therapeutics, Cronos Group, Aphria, And Canopy Growth Shares Ignited By Germany’s Medical Marijuana Law By Flodesign | Industry News
December 8, 2016 Canopy Growth’s $430M takeover of Mettrum would be biggest-ever deal in global marijuana business By Flodesign | Industry News
December 2, 2016 John Ivison: Marijuana report to urge Liberals to strike at the black market By Flodesign | Industry News
October 28, 2016 After Election Day, access to marijuana likely to reach all-time high across nation By Flodesign | Industry News
October 24, 2016 CTT Pharmaceutical Holdings to License to CanniMed Ltd. Novel Cannabis Orally Dissolvable Thin Film (ODF) Wafer Drug Delivery Technology for North American Markets By Flodesign | Press Release
February 9, 2015 CTT Announces the Appointment of Steve Abboud, SME Medicinal Marijuana to Advisory Board By Flodesign | Press Release
February 9, 2015 Mindesta Announces Acquisition of CTT Pharmaceuticals, Inc. By Flodesign | Press Release
